Mostrar el registro sencillo del ítem
dc.contributor.author | Marty, F. M. | |
dc.contributor.author | Man, C. Y. | |
dc.contributor.author | Van der Horst, C. | |
dc.contributor.author | Francois, B. | |
dc.contributor.author | Garot, D. | |
dc.contributor.author | Mánez, R. | |
dc.contributor.author | Thamlikitkul, V. | |
dc.contributor.author | Lorente Balanza, José Ángel | |
dc.contributor.author | Álvarez Lerma, Francisco | |
dc.contributor.author | Brealey, D. | |
dc.contributor.author | Zhao, H. H. | |
dc.contributor.author | Weller, S. | |
dc.contributor.author | Yates, P. J. | |
dc.contributor.author | Peppercorn, A. F. | |
dc.date.accessioned | 2015-07-17T16:55:41Z | |
dc.date.available | 2015-07-17T16:55:41Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Marty, F. M., Man, C. Y., van der Horst, C., Francois, B., Garot, D., Máňez, R., ... & Peppercorn, A. F. (2014). Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study. Journal of Infectious Diseases, 209(4), 542-50. | spa |
dc.identifier.issn | 00221899 | |
dc.identifier.issn | 15376613 | |
dc.identifier.uri | http://hdl.handle.net/11268/4210 | |
dc.description.abstract | Intravenous zanamivir is a neuraminidase inhibitor suitable for treatment of hospitalized patients with severe influenza. Patients were treated with intravenous zanamivir 600 mg twice daily, adjusted for renal impairment, for up to 10 days. Primary outcomes included adverse events (AEs), and clinical/laboratory parameters. Pharmacokinetics, viral load, and disease course were also assessed. | spa |
dc.language.iso | spa | spa |
dc.subject.other | Zanamivir | spa |
dc.title | Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study | spa |
dc.type | article | spa |
dc.description.impact | 5.997 JCR (2014) Q1, 18/148 Inmunology, 4/78 Infectious diseases, 14/119 Microbiology | spa |
dc.identifier.doi | 10.1093/infdis/jit467 | |
dc.rights.accessRights | openAccess | spa |
dc.subject.uem | Medicamentos | spa |
dc.subject.unesco | Investigación médica | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |